| scholarly article | Q13442814 |
| P50 | author | Duanqing Pei | Q5310422 |
| Hui Zheng | Q42716126 | ||
| Jiekai Chen | Q42761792 | ||
| Guangjin Pan | Q95964169 | ||
| Chengqian Feng | Q117269551 | ||
| Yunqian Guo | Q117269552 | ||
| Dajiang Qin | Q117269554 | ||
| P2093 | author name string | Wen Li | |
| Jing Liu | |||
| Hao Sun | |||
| Linli Wang | |||
| Jing Qi | |||
| Songwei He | |||
| Xiaopeng Liu | |||
| Chunlan Chen | |||
| P2860 | cites work | Evidence for mesenchymal-epithelial transition associated with mouse hepatic stem cell differentiation | Q21135539 |
| Direct cell reprogramming is a stochastic process amenable to acceleration | Q24644898 | ||
| Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins | Q24653753 | ||
| Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK | Q24672084 | ||
| Epithelial-mesenchymal transitions: insights from development | Q26865944 | ||
| Cancer invasion and the microenvironment: plasticity and reciprocity | Q27024382 | ||
| Epithelial-mesenchymal transitions in tumour progression | Q27860487 | ||
| Induced pluripotent stem cell lines derived from human somatic cells | Q27860597 | ||
| Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 | ||
| Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. | Q28131663 | ||
| Promotion of reprogramming to ground state pluripotency by signal inhibition | Q28473911 | ||
| Mechanisms and functional implications of adult neurogenesis | Q29547295 | ||
| Generation of mouse induced pluripotent stem cells without viral vectors | Q29614342 | ||
| Immunogenicity of induced pluripotent stem cells | Q29616185 | ||
| Generation of induced pluripotent stem cells using recombinant proteins | Q29619162 | ||
| A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog | Q33509682 | ||
| Mechanisms involved in valvuloseptal endocardial cushion formation in early cardiogenesis: roles of transforming growth factor (TGF)-beta and bone morphogenetic protein (BMP). | Q33823445 | ||
| Low incidence of DNA sequence variation in human induced pluripotent stem cells generated by nonintegrating plasmid expression | Q34030950 | ||
| Facilitators and impediments of the pluripotency reprogramming factors' initial engagement with the genome | Q34034406 | ||
| A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts | Q34125363 | ||
| Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming | Q34125369 | ||
| Critical and reciprocal regulation of KLF4 and SLUG in transforming growth factor β-initiated prostate cancer epithelial-mesenchymal transition | Q34243311 | ||
| Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase | Q34299819 | ||
| Mesenchymal-epithelial transition during somitic segmentation is regulated by differential roles of Cdc42 and Rac1. | Q34347783 | ||
| Mesenchyme to epithelium transition during development of the mammalian kidney tubule | Q34423679 | ||
| Transitions between epithelial and mesenchymal states in development and disease | Q34761972 | ||
| Substrate-modulated gating dynamics in a Na+-coupled neurotransmitter transporter homologue | Q35227331 | ||
| Rational optimization of reprogramming culture conditions for the generation of induced pluripotent stem cells with ultra-high efficiency and fast kinetics | Q35469739 | ||
| Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cells | Q35947171 | ||
| Reprogramming of murine and human somatic cells using a single polycistronic vector | Q37068363 | ||
| Mouse meningiocytes express Sox2 and yield high efficiency of chimeras after nuclear reprogramming with exogenous factors | Q37142823 | ||
| Role of the epithelial-mesenchymal transition regulator Slug in primary human cancers | Q37410395 | ||
| Induced pluripotent stem cells: developmental biology to regenerative medicine | Q37801268 | ||
| MET signalling: principles and functions in development, organ regeneration and cancer | Q37811895 | ||
| The EMT regulator slug and lung carcinogenesis | Q37888326 | ||
| Transcriptional activation of ZEB1 by Slug leads to cooperative regulation of the epithelial-mesenchymal transition-like phenotype in melanoma | Q38587374 | ||
| H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs | Q39234437 | ||
| Copy number variation and selection during reprogramming to pluripotency | Q39582693 | ||
| A high proliferation rate is required for cell reprogramming and maintenance of human embryonic stem cell identity | Q39618673 | ||
| Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. | Q39619885 | ||
| Cadherin switching: essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition. | Q40457821 | ||
| A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer | Q42522113 | ||
| Vitamin C enhances the generation of mouse and human induced pluripotent stem cells | Q43207059 | ||
| Generation of induced pluripotent stem cells from adult rhesus monkey fibroblasts | Q47209086 | ||
| The challenge of immunogenicity in the quest for induced pluripotency. | Q51776242 | ||
| The histone demethylases Jhdm1a/1b enhance somatic cell reprogramming in a vitamin-C-dependent manner. | Q53204519 | ||
| A negative feedback loop of transcription factors that controls stem cell pluripotency and self-renewal | Q56067490 | ||
| Generation of induced pluripotent stem cell lines from adult rat cells | Q83039078 | ||
| Vitamin C improves the quality of somatic cell reprogramming | Q83761829 | ||
| Expression of the E-cadherin repressors Snail, Slug and Zeb1 in urothelial carcinoma of the urinary bladder: relation to stromal fibroblast activation and invasive behaviour of carcinoma cells | Q84596555 | ||
| Thrombin induces slug-mediated E-cadherin transcriptional repression and the parallel up-regulation of N-cadherin by a transcription-independent mechanism in RPE cells | Q84623878 | ||
| P433 | issue | 7 | |
| P304 | page(s) | 829-838 | |
| P577 | publication date | 2013-05-26 | |
| P1433 | published in | Nature Cell Biology | Q1574111 |
| P1476 | title | Sequential introduction of reprogramming factors reveals a time-sensitive requirement for individual factors and a sequential EMT-MET mechanism for optimal reprogramming. | |
| P478 | volume | 15 |
| Q90427708 | A SIRT1-centered circuitry regulates breast cancer stemness and metastasis |
| Q40984060 | A deterministic method for estimating free energy genetic network landscapes with applications to cell commitment and reprogramming paths |
| Q34287955 | A genome-wide RNAi screen identifies opposing functions of Snai1 and Snai2 on the Nanog dependency in reprogramming |
| Q41990508 | A novel slug-containing negative-feedback loop regulates SCF/c-Kit-mediated hematopoietic stem cell self-renewal |
| Q38219856 | A prospective epigenetic paradigm between cellular senescence and epithelial-mesenchymal transition in organismal development and aging |
| Q33640161 | A sequential EMT-MET mechanism drives the differentiation of human embryonic stem cells towards hepatocytes. |
| Q38187715 | All roads lead to induced pluripotent stem cells: the technologies of iPSC generation. |
| Q90481740 | An evolving paradigm of cancer stem cell hierarchies: therapeutic implications |
| Q38376035 | Application of biomaterials to advance induced pluripotent stem cell research and therapy |
| Q52942542 | Autophagy and mTORC1 regulate the stochastic phase of somatic cell reprogramming. |
| Q34039326 | C/EBPα poises B cells for rapid reprogramming into induced pluripotent stem cells. |
| Q53323303 | Calcineurin-NFAT Signaling Controls Somatic Cell Reprogramming in a Stage-Dependent Manner. |
| Q38230318 | Cancer: pathological nuclear reprogramming? |
| Q34259132 | Cell signalling pathways underlying induced pluripotent stem cell reprogramming |
| Q89168016 | Cellular trajectories and molecular mechanisms of iPSC reprogramming |
| Q28085565 | Choices for Induction of Pluripotency: Recent Developments in Human Induced Pluripotent Stem Cell Reprogramming Strategies |
| Q38342378 | Clinical impact of studying epithelial-mesenchymal plasticity in pluripotent stem cells |
| Q38850538 | Concise Review: Application of In Vitro Transcribed Messenger RNA for Cellular Engineering and Reprogramming: Progress and Challenges |
| Q50544749 | DPPA5 Supports Pluripotency and Reprogramming by Regulating NANOG Turnover. |
| Q89129296 | DSG2 Is a Functional Cell Surface Marker for Identification and Isolation of Human Pluripotent Stem Cells |
| Q28069801 | Distinctive properties of metastasis-initiating cells |
| Q26771698 | Emerging Transcriptional Mechanisms in the Regulation of Epithelial to Mesenchymal Transition and Cellular Plasticity in the Kidney |
| Q30837218 | Energy metabolism and metabolic sensors in stem cells: the metabostem crossroads of aging and cancer |
| Q33554618 | Engineering of a synthetic quadrastable gene network to approach Waddington landscape and cell fate determination. |
| Q36499533 | Enhanced OCT4 transcriptional activity substitutes for exogenous SOX2 in cellular reprogramming. |
| Q41154014 | Enhanced generation of iPSCs from older adult human cells by a synthetic five-factor self-replicative RNA. |
| Q98771757 | Epithelial-Mesenchymal Transition and Metabolic Switching in Cancer: Lessons From Somatic Cell Reprogramming |
| Q48146199 | Epithelial-Mesenchymal Transition in Pancreatic Cancer: A Review. |
| Q38771479 | Epithelial-mesenchymal transition (EMT): A biological process in the development, stem cell differentiation, and tumorigenesis. |
| Q57283456 | Epithelial-mesenchymal transition and cancer stem cells: at the crossroads of differentiation and dedifferentiation |
| Q90457410 | Epithelial-to-mesenchymal transition in cancer: complexity and opportunities |
| Q38763748 | Epithelial-to-mesenchymal transition transcription factors in cancer-associated fibroblasts |
| Q93203291 | Exploring intermediate cell states through the lens of single cells |
| Q36686899 | Genome-wide gene expression analyses reveal unique cellular characteristics related to the amenability of HPC/HSCs into high-quality induced pluripotent stem cells |
| Q98665240 | Glis1 facilitates induction of pluripotency via an epigenome-metabolome-epigenome signalling cascade |
| Q90393478 | Heterochromatin loosening by the Oct4 linker region facilitates Klf4 binding and iPSC reprogramming |
| Q51367877 | High-efficiency cellular reprogramming with microfluidics. |
| Q33722318 | Human Lung Spheroids as In Vitro Niches of Lung Progenitor Cells with Distinctive Paracrine and Plasticity Properties. |
| Q92407494 | Human lung epithelial BEAS-2B cells exhibit characteristics of mesenchymal stem cells |
| Q59332869 | Hysteresis control of epithelial-mesenchymal transition dynamics conveys a distinct program with enhanced metastatic ability |
| Q52801310 | Identifying the Biphasic Role of Calcineurin/NFAT Signaling Enables Replacement of Sox2 in Somatic Cell Reprogramming. |
| Q90344684 | Incomplete cellular reprogramming of colorectal cancer cells elicits an epithelial/mesenchymal hybrid phenotype |
| Q38140541 | Induced pluripotency for translational research |
| Q46150911 | Induced pluripotent stem cells derived from human amnion in chemically defined conditions. |
| Q46056309 | Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson's disease model |
| Q93162389 | Inhibition of Slug effectively targets leukemia stem cells via the Slc13a3/ROS signaling pathway |
| Q47169346 | Isolation and Culture of Primary Mouse Retinal Pigment Epithelial (RPE) Cells with Rho-Kinase and TGFβR-1/ALK5 Inhibitor. |
| Q28830469 | JNK/SAPK Signaling Is Essential for Efficient Reprogramming of Human Fibroblasts to Induced Pluripotent Stem Cells |
| Q38178811 | Krüppel-like factors in cancer progression: three fingers on the steering wheel |
| Q46686884 | Large-Scale Profiling Reveals the Influence of Genetic Variation on Gene Expression in Human Induced Pluripotent Stem Cells. |
| Q58548120 | Lymphoid Enhancer Factor 1 Contributes to Hepatocellular Carcinoma Progression Through Transcriptional Regulation of Epithelial-Mesenchymal Transition Regulators and Stemness Genes |
| Q37144506 | Lysine-specific histone demethylase 1 inhibition promotes reprogramming by facilitating the expression of exogenous transcriptional factors and metabolic switch. |
| Q33943321 | Mechanisms for enhancing cellular reprogramming |
| Q26745545 | Mechanisms of TGFβ-Induced Epithelial-Mesenchymal Transition |
| Q90854375 | Mesenchymal-epithelial transition in development and reprogramming |
| Q36967449 | Meta-Analysis of EMT Datasets Reveals Different Types of EMT. |
| Q35288003 | Metabolic reprogramming during TGFβ1-induced epithelial-to-mesenchymal transition |
| Q89850962 | Metabolic switch and epithelial-mesenchymal transition cooperate to regulate pluripotency |
| Q39114556 | Myofibroblastic cells function as progenitors to regenerate murine livers after partial hepatectomy. |
| Q64257065 | New Insights into the Role of Epithelial⁻Mesenchymal Transition during Aging |
| Q26861483 | Non-viral methods for generating integration-free, induced pluripotent stem cells |
| Q35020560 | Novel codon-optimized mini-intronic plasmid for efficient, inexpensive, and xeno-free induction of pluripotency. |
| Q52975664 | Novel mouse model recapitulates genome and transcriptome alterations in human colorectal carcinomas. |
| Q37317175 | Novel signaling collaboration between TGF-β and adaptor protein Crk facilitates EMT in human lung cancer |
| Q64964513 | Nuclear CD44 Mediated by Importin β Participated in Naïve Genes Transcriptional Regulation in C3A-iCSCs. |
| Q37420064 | Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway |
| Q41785224 | OCT4: A penetrant pluripotency inducer. |
| Q90597105 | Oct4 mediates Müller glia reprogramming and cell cycle exit during retina regeneration in zebrafish |
| Q38951334 | Oncometabolic Nuclear Reprogramming of Cancer Stemness |
| Q91669676 | One-Step Generation of a Drug-Releasing Hydrogel Microarray-On-A-Chip for Large-Scale Sequential Drug Combination Screening |
| Q37589137 | Ovarian cancer stem-like cells show induced translineage-differentiation capacity and are suppressed by alkaline phosphatase inhibitor |
| Q47781833 | Passive DNA demethylation preferentially up-regulates pluripotency-related genes and facilitates the generation of induced pluripotent stem cells |
| Q92377031 | Pluripotency reprogramming by competent and incompetent POU factors uncovers temporal dependency for Oct4 and Sox2 |
| Q100526320 | Proliferation and EMT trigger heart repair |
| Q33659098 | Promyelocytic Leukemia Protein Is an Essential Regulator of Stem Cell Pluripotency and Somatic Cell Reprogramming. |
| Q38602987 | Reduced expression of Paternally Expressed Gene-3 enhances somatic cell reprogramming through mitochondrial activity perturbation |
| Q26853155 | Reprogramming cells with synthetic proteins |
| Q36124946 | Reprogramming during epithelial to mesenchymal transition under the control of TGFβ |
| Q47141894 | Reprogramming to pluripotency does not require transition through a primitive streak-like state. |
| Q35819298 | Restoration of mesenchymal retinal pigmented epithelial cells by TGFβ pathway inhibitors: implications for age-related macular degeneration |
| Q33742361 | Sequential EMT-MET induces neuronal conversion through Sox2. |
| Q50865341 | Sequential addition of reprogramming factors improves efficiency. |
| Q93382557 | Sialylation is involved in cell fate decision during development, reprogramming and cancer progression |
| Q47344591 | Size-dependent effects of layered double hydroxide nanoparticles on cellular functions of mouse embryonic stem cells |
| Q41606525 | Small RNA changes en route to distinct cellular states of induced pluripotency. |
| Q33676275 | Specificity protein 1 (Sp1) maintains basal epithelial expression of the miR-200 family: implications for epithelial-mesenchymal transition |
| Q34707863 | Sphere formation permits Oct4 reprogramming of ciliary body epithelial cells into induced pluripotent stem cells |
| Q33742151 | Staged miRNA re-regulation patterns during reprogramming |
| Q53192333 | Stiffness of Hydrogels Regulates Cellular Reprogramming Efficiency Through Mesenchymal-to-Epithelial Transition and Stemness Markers. |
| Q36067750 | Suppression of epithelial-mesenchymal transition and apoptotic pathways by miR-294/302 family synergistically blocks let-7-induced silencing of self-renewal in embryonic stem cells |
| Q96685709 | TFAP2C facilitates somatic cell reprogramming by inhibiting c-Myc-dependent apoptosis and promoting mesenchymal-to-epithelial transition |
| Q64992785 | Targeting slug-mediated non-canonical activation of c-Met to overcome chemo-resistance in metastatic ovarian cancer cells. |
| Q38988591 | The Role of Indirubins in Inflammation and Associated Tumorigenesis. |
| Q34729447 | The dyskerin ribonucleoprotein complex as an OCT4/SOX2 coactivator in embryonic stem cells |
| Q34533755 | The epithelial-mesenchymal transition factor SNAIL paradoxically enhances reprogramming |
| Q37194184 | The role of telomeres and telomerase reverse transcriptase isoforms in pluripotency induction and maintenance |
| Q64894373 | The transcription factor Slug represses p16Ink4a and regulates murine muscle stem cell aging. |
| Q28833688 | Toward pluripotency by reprogramming: mechanisms and application |
| Q34037104 | Transitions between epithelial and mesenchymal states during cell fate conversions |
| Q50063155 | Tumor suppressor miR-128-3p inhibits metastasis and epithelial-mesenchymal transition by targeting ZEB1 in esophageal squamous-cell cancer |
| Q33720285 | Understanding the roadmaps to induced pluripotency. |
| Q30364669 | Where cell fate conversions meet Chinese philosophy. |
| Q42321676 | miR302 regulates SNAI1 expression to control mesangial cell plasticity |
| Q87165535 | miRNAs promote generation of porcine-induced pluripotent stem cells |
Search more.